Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Stoke Therapeutics, Inc. (STOK) had Receiveable Turnover of 0.18 for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$1.40M |
|
$-57.93M |
|
-- |
|
$1.40M |
|
$62.84M |
|
$-61.44M |
|
$3.50M |
|
$-57.93M |
|
$-57.93M |
|
$-57.93M |
|
$-57.93M |
|
$-57.93M |
|
$-57.93M |
|
$-61.44M |
|
$-61.59M |
|
59.22M |
|
59.22M |
|
$-1.02 |
|
$-0.97 |
|
| Balance Sheet Financials | |
$305.70M |
|
$3.15M |
|
$112.73M |
|
$418.43M |
|
$57.88M |
|
-- |
|
$8.10M |
|
$65.98M |
|
$352.46M |
|
$352.46M |
|
$352.46M |
|
58.92M |
|
| Cash Flow Statement Financials | |
$45.59M |
|
$-186.81M |
|
$97.39M |
|
$128.78M |
|
$84.94M |
|
$-43.84M |
|
$32.24M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.28 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4382.26% |
|
-4382.26% |
|
-- |
|
-4132.26% |
|
-4132.26% |
|
$44.91M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
|
Receiveable Turnover |
0.18 |
507.46 |
|
-16.44% |
|
-16.44% |
|
-13.85% |
|
-16.44% |
|
$5.98 |
|
$0.76 |
|
$0.77 |
|